Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed‐loop? The CLOSE AP + randomized controlled trial
Diabetes, Obesity and Metabolism · 2024-02 · 26 (2) · 622-630
DOI: 10.1111/dom.15351 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 03.11.2023. Verfasst von Yves Reznik und 11 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex, France and Unicaen, Caen Cedex, France. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Hypoglycemia, Home Care Services. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Air Liquide Sante International, European Institute of Innovation and Technology, H2020 European Institute of Innovation and Technology.
Themen: Ambulante Pflege, Diabetes mellitus
Abstract (Originalsprache)
Aim
The study aim was to evaluate the feasibility, safety and efficacy of automated insulin delivery (AID) assisted by home health care (HHC) services in people with type 2 diabetes unable to manage multiple daily insulin injections (MDI) at home on their own. Patients and Methods This was an open label, multicentre, randomized, parallel group trial. In total, 30 adults with type 2 diabetes using MDI and requiring nursing support were randomly allocated to AID or kept their usual therapy over a 12‐week period. Both treatments were managed with the support of HHC services. The primary outcome was the percentage time in the target glucose range of 70‐180 mg/dl (TIR). Secondary outcomes included other continuous glucose monitoring metrics, glycated haemoglobin (HbA1c) levels, daily insulin doses, body weight, and of quality of life scores, fear of hypoglycaemia and satisfaction questionnaires.
Results
Age (69.7 vs. 69.3 years) and HbA1c (9.25 vs. 9.0) did not differ in MDI and AID at baseline. Compared with MDI, AID resulted in a significant increase in TIR by 27.4% [95% CI (15.0‐39.8); p < .001], a decrease in time above range by 27.7% and an unchanged time below range of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology and Diabetes Department, CHU Côte de Nacre, Caen Cedex, France and Unicaen, Caen Cedex, France.
- Diabetology Department, Vert Coteau Clinic, Marseille, France.
- Diabetology Department, Amiens University Hospital, Amiens, France.
- Normandie Univ, UNIROUEN, Inserm U1239, CHU Rouen, Department of Endocrinology, Diabetes and metabolic diseases and Inserm CIC-CRB 140, Rouen, France.
- Diabetology Department, Nantes University Hospital, Nantes, France.
- Centre Universitaire du diabète et de ses complications, APHP, Hôpital Lariboisière, Paris, Île-de-France, France and Institut Necker Enfants Malades, INSERM U1151, CNRS UMR 8253, IMMEDIAB Laboratory, Paris, France.
ORCID-Profile: Yves Reznik, Hélène Hanaire, Beata Mianowska, Eric Renard
Förderung
- Air Liquide Sante International
- European Institute of Innovation and Technology
- H2020 European Institute of Innovation and Technology
Zitieren
APA
Reznik, Y., Carvalho, M., Fendri, S., Prevost, G., Chaillous, L., Riveline, J. P., Hanaire, H., Dubois, S., Houéto, P., Pasche, H., Mianowska, B., & Renard, E. (2024). Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed‐loop? The CLOSE AP + randomized controlled trial. Diabetes, Obesity and Metabolism, 26(2), 622-630. https://doi.org/10.1111/dom.15351
Vancouver
Reznik Y, Carvalho M, Fendri S, Prevost G, Chaillous L, Riveline JP, et al. Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed‐loop? The CLOSE AP + randomized controlled trial. Diabetes, Obesity and Metabolism. 2024;26(2):622-630. doi:10.1111/dom.15351
BibTeX
@article{Reznik2024,
author = {Reznik, Yves and Carvalho, Martin and Fendri, Salha and Prevost, Gaetan and Chaillous, Lucy and Riveline, Jean Pierre and Hanaire, Hélène and Dubois, Séverine and Houéto, Patrick and Pasche, Hélène and Mianowska, Beata and Renard, Eric},
title = {Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed‐loop? The CLOSE AP + randomized controlled trial},
journal = {Diabetes, Obesity and Metabolism},
year = {2024},
volume = {26},
number = {2},
pages = {622--630},
doi = {10.1111/dom.15351}
}
EUVIMED